Rational Design, Synthesis, in Vitro, and In-silico Studies of Pyrazole‑phthalazine Hybrids As New α‑glucosidase Inhibitors

Overview

Journal Sci Rep

Date 2025 Jan 30

PMID 39885319

Authors

Mehrdad Roshan

Roghieh Mirzazadeh

Azadeh Tajmir-Riahi

Mohammad Sadegh Asgari

Affiliations

Soon will be listed here.

Abstract

This paper describes the design, development, synthesis, in silico, and in vitro evaluation of fourteen novel heterocycle hybrids as inhibitors of the α-glucosidase enzyme. The primary aim of this study was to explore the potential of novel pyrazole-phthalazine hybrids as selective inhibitors of α-glucosidase, an enzyme involved in carbohydrate metabolism, which plays a key role in the management of type 2 diabetes. The rationale for this study stems from the need for new, more effective inhibitors of α-glucosidase with improved efficacy and safety profiles compared to currently available therapies like Acarbose. The synthesized compounds were tested against the yeast α-glucosidase enzyme and showed significantly higher activity than the standard drug Acarbose. The IC50 values ranged from 13.66 ± 0.009 to 494 ± 0.006 μM, compared to the standard drug Acarbose (IC50 = 720.18 ± 0.008). The most effective α-glucosidase inhibitor, 2-acetyl-1-(3-(4-methoxyphenyl)-1-phenyl-1H-pyrazol-4-yl)-3-methyl-1H-pyrazolo[1,2-b]phthalazine-5,10-dione (8l), was identified through a kinetic binding study that yielded an inhibition constant, Ki, of 34.75 µM. All of the pharmacophoric features used in the hybrid design were found to be involved in the interaction with the enzyme's active site, as expected. Moreover, molecular dynamic simulation and the absorption, distribution, metabolism, and excretion (ADME) have been performed.

References

van der Spoel D, Lindahl E, Hess B, Groenhof G, Mark A, Berendsen H . GROMACS: fast, flexible, and free. J Comput Chem. 2005; 26(16):1701-18. DOI: 10.1002/jcc.20291. View

Watanabe N, Kabasawa Y, Takase Y, Matsukura M, Miyazaki K, Ishihara H . 4-Benzylamino-1-chloro-6-substituted phthalazines: synthesis and inhibitory activity toward phosphodiesterase 5. J Med Chem. 1998; 41(18):3367-72. DOI: 10.1021/jm970815r. View

Azimi F, Ghasemi J, Azizian H, Najafi M, Faramarzi M, Saghaei L . Design and synthesis of novel pyrazole-phenyl semicarbazone derivatives as potential α-glucosidase inhibitor: Kinetics and molecular dynamics simulation study. Int J Biol Macromol. 2020; 166:1082-1095. DOI: 10.1016/j.ijbiomac.2020.10.263. View

Huard K, Bagley S, Menhaji-Klotz E, Preville C, Southers Jr J, Smith A . Synthesis of spiropiperidine lactam acetyl-CoA carboxylase inhibitors. J Org Chem. 2012; 77(22):10050-7. DOI: 10.1021/jo3014808. View

Nomoto Y, Obase H, Takai H, Teranishi M, Nakamura J, Kubo K . Studies on cardiotonic agents. II. Synthesis of novel phthalazine and 1,2,3-benzotriazine derivatives. Chem Pharm Bull (Tokyo). 1990; 38(8):2179-83. DOI: 10.1248/cpb.38.2179. View

Ren B, Liu R, Ji K, Tang J, Gao J . Design, synthesis and in vitro antitumor evaluation of novel pyrazole-benzimidazole derivatives. Bioorg Med Chem Lett. 2021; 43:128097. DOI: 10.1016/j.bmcl.2021.128097. View

Li J, Zhao Y, Yuan X, Xu J, Gong P . Synthesis and anticancer activities of novel 1,4-disubstituted phthalazines. Molecules. 2007; 11(7):574-82. PMC: 6148564. DOI: 10.3390/11070574. View

Bebernitz G, Argentieri G, Battle B, Brennan C, Balkan B, Burkey B . The effect of 1,3-diaryl-[1H]-pyrazole-4-acetamides on glucose utilization in ob/ob mice. J Med Chem. 2001; 44(16):2601-11. DOI: 10.1021/jm010032c. View

Simijonovic D, Petrovic Z, Milovanovic V, Petrovic V, Bogdanovic G . A new efficient domino approach for the synthesis of pyrazolyl-phthalazine-diones. Antiradical activity of novel phenolic products. RSC Adv. 2022; 8(30):16663-16673. PMC: 9080326. DOI: 10.1039/c8ra02702a. View

10.

Amado P, Costa I, Paixao J, Mendes R, Cortes S, Cristiano M . Synthesis, Structure and Antileishmanial Evaluation of Endoperoxide-Pyrazole Hybrids. Molecules. 2022; 27(17). PMC: 9457810. DOI: 10.3390/molecules27175401. View

11.

Yamali C, Sakagami H, Uesawa Y, Kurosaki K, Satoh K, Masuda Y . Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides. Eur J Med Chem. 2021; 217:113351. DOI: 10.1016/j.ejmech.2021.113351. View

12.

Ryu C, Park R, Ma M, Nho J . Synthesis and antifungal activity of 6-arylamino-phthalazine-5,8-diones and 6,7-bis(arylthio)-phthalazine-5,8-diones. Bioorg Med Chem Lett. 2007; 17(9):2577-80. DOI: 10.1016/j.bmcl.2007.02.003. View

13.

Shen D, Brady E, Candelore M, Dallas-Yang Q, Ding V, Feeney W . Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core. Bioorg Med Chem Lett. 2010; 21(1):76-81. DOI: 10.1016/j.bmcl.2010.11.074. View

14.

Taslimi P, Turhan K, Turkan F, Sedef Karaman H, Turgut Z, Gulcin I . Cholinesterases, α-glycosidase, and carbonic anhydrase inhibition properties of 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives: Synthetic analogues for the treatment of Alzheimer's disease and diabetes mellitus. Bioorg Chem. 2020; 97:103647. DOI: 10.1016/j.bioorg.2020.103647. View

15.

Ozil M, Emirik M, Etlik S, Ulker S, Kahveci B . A simple and efficient synthesis of novel inhibitors of alpha-glucosidase based on benzimidazole skeleton and molecular docking studies. Bioorg Chem. 2016; 68:226-35. DOI: 10.1016/j.bioorg.2016.08.011. View

16.

Rikimaru K, Wakabayashi T, Abe H, Imoto H, Maekawa T, Ujikawa O . A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: design and synthesis of benzylpyrazole acylsulfonamides. Bioorg Med Chem. 2012; 20(2):714-33. DOI: 10.1016/j.bmc.2011.12.008. View

17.

Philoppes J, Khedr M, Hassan M, Kamel G, Lamie P . New pyrazolopyrimidine derivatives with anticancer activity: Design, synthesis, PIM-1 inhibition, molecular docking study and molecular dynamics. Bioorg Chem. 2020; 100:103944. DOI: 10.1016/j.bioorg.2020.103944. View

18.

Durantel D, Alotte C, Zoulim F . Glucosidase inhibitors as antiviral agents for hepatitis B and C. Curr Opin Investig Drugs. 2007; 8(2):125-9. View

19.

Humphries M, Matsumoto K, White S, Olden K . Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res. 1986; 46(10):5215-22. View

20.

Pogaku V, Gangarapu K, Basavoju S, Tatapudi K, Katragadda S . Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors. Bioorg Chem. 2019; 93:103307. DOI: 10.1016/j.bioorg.2019.103307. View